Clinical trials
Completed Phase 3 Hepatitis C trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
206 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 10 |
| 2003 | 6 |
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 6 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 18 |
| 2012 | 25 |
| 2013 | 21 |
| 2014 | 27 |
| 2015 | 28 |
| 2016 | 19 |
| 2017 | 13 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 206 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 40 |
| Gilead Sciences | 34 |
| Bristol-Myers Squibb | 24 |
| Janssen R&D Ireland | 7 |
| Merck Sharp & Dohme LLC | 7 |
| AbbVie (prior sponsor, Abbott) | 6 |
| Boehringer Ingelheim | 4 |
| Janssen Pharmaceutical K.K. | 4 |
| Janssen-Cilag International NV | 4 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 206 |
| Hepatitis C, Chronic | 73 |
| Fibrosis | 24 |
| Hepatitis | 12 |
| Virus Diseases | 11 |
| Liver Diseases | 10 |
| Acquired Immunodeficiency Syndrome | 7 |
| Liver Cirrhosis | 7 |
| Hepatitis, Chronic | 6 |
| Hepatitis, Viral, Human | 6 |
Trials
Showing 1 to 25 of 206. Each trial links to its page on Pharma Observatory.
106 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.